ICD-10 Code T46.6X5

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs

Version 2019 Replaced Code Non-Billable Code Adverse Effect
ICD-10:T46.6X5
Short Description:Adverse effect of antihyperlipidemic and antiarterio drugs
Long Description:Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs

Not Valid for Submission

ICD-10 T46.6X5 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of adverse effect of antihyperlipidemic and antiarteriosclerotic drugs. The code is NOT valid for the year 2019 for the submission of HIPAA-covered transactions.

Consider the following ICD-10 codes with a higher level of specificity:

  • T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
  • T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
  • T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela

Deleted Code

This code was deleted in the 2019 ICD-10 code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2018. This code was replaced for the FY 2019 (October 1, 2018 - September 30, 2019).

  • K59.03 - Drug induced constipation

Code Classification

  • Injury, poisoning and certain other consequences of external causes (S00–T98)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
      • Agents primarily affecting the cardiovascular system (T46)

Information for Medical Professionals

Diagnostic Related Groups

The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). The diagnosis code T46.6X5 is grouped in the following groups for version MS-DRG V36.0 applicable from 10/01/2018 through 09/30/2019.

  • 922 - OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC
  • 923 - OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC
  • 949 - AFTERCARE WITH CC/MCC
  • 950 - AFTERCARE WITHOUT CC/MCC

Synonyms

The following clinical terms are approximate synonyms:

  • Acipimox adverse reaction
  • Adverse reaction caused by atorvastatin
  • Adverse reaction caused by cerivastatin
  • Adverse reaction caused by fluvastatin
  • Adverse reaction caused by lovastatin
  • Adverse reaction caused by pitavastatin
  • Adverse reaction caused by pravastatin
  • Adverse reaction caused by rosuvastatin
  • Adverse reaction caused by simvastatin
  • Anion exchange resins adverse reaction
  • Bezafibrate adverse reaction
  • Cholestyramine adverse reaction
  • Ciprofibrate adverse reaction
  • Clofibrate adverse reaction
  • Colestipol adverse reaction
  • Fenofibrate adverse reaction
  • Fibrate antihyperlipidemic adverse reaction
  • Gemfibrozil adverse reaction
  • Guar gum adverse reaction
  • HMG COA reductase inhibitor adverse reaction
  • Ion exchange resin adverse reaction
  • Lipid-lowering drug adverse reaction
  • Myalgia caused by statin
  • Probucol adverse reaction

Table of Drugs and Chemicals

The code T46.6X5 is included in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. Use as many codes as necessary to describe all reported drugs, medicinal or chemical substances.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
self-harm
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
AcipimoxT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antiarteriosclerotic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Anticholesterolemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antihyperlipidemic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antilipemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenfluorexT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-benzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-sitosterol (s)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BezafibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BinifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholesterol-lowering agentsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholestyramine (resin)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
CiprofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClinofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Clotibric acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestipolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestyramineT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cyamopsis tetragono-lobaT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
DetaxtranT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Ethylparachlorophen-oxyisobutyrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtiroxateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
FenofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
GemfibrozilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Guar gum (medicinal)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
HalofenateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linoleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linolenic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
LovastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
MesoglycanT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Oleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PirozadilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Polidexide (sulfate)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PravastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ProbucolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
RonifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Safflower oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimfibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimvastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SitosterolsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SoysterolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Sunflower seed oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
TriparanolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Unsaturated fatty acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6

Information for Patients


Drug Reactions

Also called: Side effects

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions.

One problem is interactions, which may occur between

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as ginkgo and blood thinners
  • Drugs and diseases, such as aspirin and peptic ulcers

Interactions can change the actions of one or both drugs. The drugs might not work, or you could get side effects.

Side effects are unwanted effects caused by the drugs. Most are mild, such as a stomach aches or drowsiness, and go away after you stop taking the drug. Others can be more serious.

Drug allergies are another type of reaction. They can be mild or life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is more rare.

When you start a new prescription or over-the-counter medication, make sure you understand how to take it correctly. Know which other medications and foods you need to avoid. Ask your health care provider or pharmacist if you have questions.

  • Angioedema (Medical Encyclopedia)
  • Drug allergies (Medical Encyclopedia)
  • Drug-induced diarrhea (Medical Encyclopedia)
  • Drug-induced tremor (Medical Encyclopedia)
  • Taking multiple medicines safely (Medical Encyclopedia)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.